Diterpenoids are a class of compounds that derive from the condensation of four isoprene units that leads to a wide variety of complex chemical structures, including acyclic bi-, tri-and tetra-cyclic compounds; in Salvia species, only bi-, tri-and tetra-cyclic compounds have been found. This review covers a wide range of biological activities and mode of action of diterpenoids isolated from Salvia species that might raise some pharmacological and pharmaceutical interest.
Introduction
Salvia genus, belonging to the Lamiaceae or Labiatae family, is composed of about 900 species. The plants are typically herbaceous or suffruticose and are mostly perennial. Although Salvia species are common throughout the world, they are most concentrated in temperate and subtropical regions [1] .
The name Salvia comes from the Latin word salvare, verb salvare (to heal or to save), in reference to the well known curative properties of this specie. The Salerno Medical School (11th and 12th centuries), depositary of ancient medical knowledge, considered this plant to be the miracle herb par excellence and named it Salvia salvatrix. Later, in the middle of the '700, the Swedish biologist and naturalist Linneo (father of binomial nomenclature for the systemic classification of plants and animals) assigned the name officinalis to this plant. In folk medicine, Salvia species have been used to treat cold, bronchitis, tuberculosis, haemorrhage and menstrual disorders [2] . Today, there is a great interest in the study of biological properties of terpenes that are the main secondary metabolites of the plants of the genus Salvia. They include a wide range of di-, tri-, sesqui-and tetraterpenoids; most of them have been investigated for their pharmacological activities.
This review begins with the presentation of the major biand tricyclic secondary metabolites of several Salvia species, such as S. leriaefolia, S. divinorum, S. splendens, S. leucantha, S. jamensis, S. polystachia, S. officinalis, S. alfricana-lutea, S. microphylla, S. sclarea, S. yunnanensis, S. prionitis, S. miltiorrhiza, S. przewalskii, S. lanigera, S. broussonetii, S. gilliessi, S. corrugate, S. pubescens, S. cinnabarina and S. hispanica, that might raise pharmacological and pharmaceutical interest. (17) ,12 E, 14-labdatrien-6,19-olide Several clerodane diterpenoids have been isolated from Salvia divinorum (Figure 2 ), among them there are salvinorin A, divinatorin and salvinicin A [6] . All clerodanes from Salvia divinorum have been evaluated for their central effects, since hallucinogenic Salvia divinorum has been used as recreational drug. It has been demonstrated that most of clerodanes, such as salvinorin A, salvinorin B, salvinorin G, divinatorin D have agonistic activity to opioid receptor since they display significant binding at the Gαi-coupled human κ opioid receptor (KOR), salvinorin A being the most potent [7] [8] [9] . On the contrary, for salvinicin A and salvinicin B (Figure 2 ), other clerodanes found in Salvia divinorum, it has been described a partial agonistic activity on k opioid receptor and an antagonistic activity on µ opioid receptor, respectively [10] . Figure 3 ), isolated from Salvia splendens [11] , have been tested for their affinity for human μ, δ and κ opioid receptors but none of them showed high affinity binding [12] .
Four clerodane compounds, salvisplendins A-D (
Recently, Capasso et al. [13, 14] have shown that salvinorin A reduces inflammation -induced intestinal hypermotility in mice, revealing a functional interaction not only with KORs receptors but also with cannabinoid CB1 receptors. Salvileucalin B (Figure 4 ), a clerodane diterpenoid from Salvia leucantha, has shown cytotoxic activity in A549 (carcinomic human alveolar basal epithelial cells) and HT-29 (human colon adenocarcinoma) cell lines [15] while, 15,16-epoxy-cleroda-3-en-7,10-dihydroxy-12,17,19,18-diolide ( Figure 4 ), a clerodane diterpenoids from Salvia jamensis has been found to increase adenosine-5'-diphosphate (ADP) -induced platelet aggregation in vitro [16] . Linearolactone ( Figure  5 ), a clerodane diterpenoid isolated from Salvia polystachia, has shown to have antiprotozoal activity in vitro against Entamoeba histolytica and Giardia Lamblia, with IC 50 of 22.9 and 28.2 µM respectively [17] . Abietane-type are further classified as phenolic, quinonic and icetaxane. It is know that phenolic diterpene compounds, including carnosic acid, carnosol, ferruginol, 7-methoxyrosmanol and galdosol ( Figure 6 ), obtained from Salvia species, exhibit a variety of biological activities [2] . Experimental studies have demonstrated that carnosic acid and carnosol from S. officinalis and S. africana-lutea inhibited pancreatic lipase activity; however, only carnosic acid was able to inhibit serum triglyceride elevation in olive oil loaded mice [18] . Both compounds are activators of the human peroxisome proliferator-activated receptor gamma (PPAR-γ) and this activation increases the transcription of enzymes involved in primary metabolism, leading to low blood levels of fatty acids and glucose [19] . Carnosic acid and carnosol have Linearolactone also shown pronounced antioxidant and anti-inflammatory effects. They inhibited pro-inflammatory leukotriene production in intact human polymorphonuclear leukocytes (PMNL) and they both potently antagonised intracellular Ca 2+ mobilisation induced by a chemotactic stimulus [20] .
Tri-cyclic diterpenoids
Furthermore, carnosic acid from Salvia africana-lutea have shown antimicrobial activity exhibiting a MIC of 28 µM, against Mycobacterium tuberculosis and also cytotoxic activity against a breast human cancer cell line (MCF-7), with an IC 50 of 69 µM [21] . In another study, carnosol from Salvia officinalis showed a weak antimicrobial activity; however, it is worth noting that it was able to greatly reduce MICs of various aminoglycosides and of some other types of antimicrobial agents in vancomycin-resistant enterococci, having a synergistic effect. A similar activity was also shown for carnosic acid [22] . A diterpene, carnosic acid 12-methyl ether (12-methoxycarnosic acid; Figure 6 ), isolated from the acetone extract of Salvia microphylla, possesses antimicrobial activity against Staphylococcus aureus [23] . 7-methoxyrosmanol and galdosol ( Figure 6 ), isolated from Salvia officinalis, might have a potential activity on Central Nervous System (CNS) since their ability to bind the benzodiazepine receptor [24] .
Ferruginol ( Figure 6 ), isolated from Salvia sclarea, has been shown to possess bacteriostatic and bactericidal activity for the cultures of Staphylococcus aureus and Staphylococcus epidermidis [25] . Royleanone, horminone and acetyl horminone ( Figure 8 ), three abietanes quinoni isolated from Salvia officinalis, have been shown to have cytotoxic activity on human colonic carcinoma cells (Caco2) and human hepatoma cells (Hep G2) by damaging DNA; however, the underlying mechanism still needs to be clarified [27] . Other two abietane-quinone type diterpenoids, yunnannin A and danshenol C ( Figure 9 ), isolated from Salvia yunnanensis, have shown antitumor activity when tested on several human cancer cell lines, T-24 (bladder carcinoma), K562 (erythromyeloblastoid leukaemia), Me180 (cervical cancer) and BIU87 (bladder cancer) [28] . Figure 10 ), has shown cytotoxic activities against HL-60 human leukaemia cells and the SGC-7901 and MK-28 stomach cancer cell lines [29] . Several quinone diterpenoids that have biological activity have been found in Salvia miltiorrhiza, used as therapeutic remedy in chinese traditional medicine [30] . Tanshinones (Figure 11 ) are the most bioactive compounds and their biological activities have been extensively investigated [31] . A recent study [32] has shown the anticancer activity of tanshinones, an effect associated to their ability to inhibit hypoxia-inducible factor-1 (HIF-1) accumulation. Authors report that sibiriquinone A, sibiriquinone B, cryptotanshinone and dihydrotanshinone I potently inhibit HIF-1 expression on AGS cells, a human gastric cancer cell line, and on Hep3B cells, a human hepatocarcinoma cell line. This finding has led to hypothesize an anticancer activity of these compounds since HIF-1 has been implicated in cancer cell proliferation [33] .
Furthermore, recently, anti-cancer activity of tanshinone I ( Figure 11 ) has also been reported by investigating the in vitro effect of tanshinone I on the induction of apoptosis in human breast cancer cells, MCF-7, oestrogen receptor positive, and MDA-MB-231, oestrogen receptor negative. Tanshinone I inhibited cell proliferation of both cell lines, MCF-7 and MDA-MB-231, in a concentration-and timedependent fashion and significantly induced apoptosis of these cells. The effect was associated to the activation of caspase 3 and to the altered ratio between Bcl-2 and Bax protein levels [34] . Indeed, the Bcl-2 and Bax genes have been reported to be linked with the regulation of programmed cell death; in response to apoptotic stimuli, Bax oligomerizes and translocates to the outer mitochondrial membrane where it induces mitochondrial membrane permeabilization and cytochrome C release. Overexpression of the anti-apoptotic protein, Bcl-2, has been found to stabilize the outer membrane and to prevent the release of cytochrome C following a variety of insults [35] .
Another work shows that tanshinone I significantly reduces adhesion of either monocyte U937 or MDA-MB-231 cells to human umbilical vein endothelial cells (HUVECs), by inhibiting ICAM-1 and VCAM-1 expressions in HUVECs. In addition, tanshinone I effectively inhibits TNFα-induced production of vascular endothelial growth factor (VEGF) and VEGF-mediated tube formation in HUVECs. Tanshinone I also inhibits TNFα -induced VEGF production in MDA-MB-231 cells and migration of MDA-MB-231 cells through extracellular matrix. Additionally, reduction of tumour mass volume and decrease of metastasis incidence by tanshinone I was observed in vivo [36] .
A recent study performed, in vitro, on the highly invasive human lung adenocarcinoma cell line, CL1-5, and, in vivo, on genetically immunodeficient mice bearing CL1-5, shows that tanshinone I is able to significantly reduce tumorigenesis and metastasis through a mechanisms involving platelet derived growth factor β (PDGF -β) signal and its downstream pathway [37] .
The effects of tanshinone derivatives (tanshinone I, cryptotanshinone, 15,16-dihydrotanshinone I) on prostaglandin (PG) and nitric oxide (NO) metabolism were also reported. Jeon et al. [38] have recently demonstrated Biological activity of bicyclic and tricyclic diterpenoids Natural Product Communications Vol. 6 (8) 2011 1209 that cyclooxygenase-2 (COX-2)-mediated PGE 2 production, from lipopolysaccharide-treated RAW 264.7 cells, is inhibited by tanshinone I, cryptotanshinone and 15,16-dihydrotanshinone I (Figure 11 ), while only cryptotanshinone and 15,16-dihydrotanshinone I inhibit inducible NO synthase (iNOS)-mediated NO production and the activation of the transcription factors, such as nuclear transcription factor-kB (NFkB) and activator protein-1 (AP-1). Furthermore, cryptotanshinone downregulates proinflammatory molecule expression, such as COX-2 and iNOS and, in vivo, it inhibits carrageenininduced rat paw oedema, a well known inflammation model sustained by arachidonic acid metabolites [38] . Jin and co-workers [39] have shown that cryptotanshinone protects rats from myocardial ischemia -reperfusion injury by inhibiting inflammatory cytokine production, adhesion molecule expression and neutrophil migration. Tanshinone IIA (Figure 11 ), a diterpene quinone extracted from Salvia miltiorrhiza, has been reported to have apoptotic inducing effects on a large variety of cancer cells with a mechanism involving the activation of caspase-3, down regulation of anti-antiapoptotic protein Bcl-2 and Bcl-xl and the up regulation of pro-apoptotic protein Bax [40] , similarly to tanshinone I. A study performed on HeLa cell, a human epithelial carcinoma cell line, highly proliferative, has shown that in comparison with other anticancer drugs causing mitotic arrest by interfering with the microtubule structure (such as vincristine or taxol), tanshinone IIA destroys only the mitotic spindle during the M phase but not the microtubule structure in interphase cells [41] . More recently, Liu and co-workers [42] have confirmed the pro-apoptotic effect of tanshinone IIA on leukaemia THP-1 cell line; also in this case the effect is associated to Bcl-2 destruction and Bax up regulation. In another work, Kim et al. [43] have shown that tanshinone IIA ( Figure 11 ) completely inhibits osteoclastogenesis, indicating a correlation between Salvia miltiorrrhiza extract-inhibitory effect on osteoporosis and its chemical metabolites. Several authors have extensively described cardiovascular beneficial effects of tanshinone IIA; it protects cardiac myocytes against oxidative stress-triggered damage and apoptosis [44] and reduces macrophage death induced by hydrogen peroxide by up regulating glutathione peroxidase [45] . Tanshinone IIA decreases the transcription level of microsomal triglyceride transfer protein gene, suggesting that it inhibits apoprotein B (ApoB) secretion via a proteasome-dependent pathway [46] . Recently, it has also been reported that tanshinone I, tanshinone IIA and 15,16dihydrotanshinone I, from Salvia miltiorrhiza, enhance the activity of insulin on the tyrosine phosphorylation of the insulin receptor (IR) β-subunit and the activation of the downstream kinases signalling in vitro in chinese hamster ovary cells expressing human insulin receptors; furthermore, the three tanshinones stimulate glucose transporter 4 (GLUT4) translocation on adipocytes [47] .
Tanshinone IIA has been shown to reduce atheroma in a rabbit model of atherosclerosis induced by high fat diet through a mechanism dependent on matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9) expression down regulation, and to reduce serum levels of vascular cell adhesion molecule-1 (VCAM-1) and IL-1β [48] .
Tanshinone IIA inhibits human aortic smooth muscle cell (HASMC) migration suggesting a beneficial effect in vascular remodelling triggered by several diseases [49] . Furthermore, tanshinone IIA has been shown to relax rat coronary artery in vitro with an endothelium dependent mechanism [50] ; it has also a beneficial effect in a rat model of myocardial infarction [51] . In order to investigate on compounds responsible for the vascular activity of the lipophilic fraction of Salvia milthiorriza and Salvia przewalskii, Wan et al. [52] performed an in vitro study on tanshinone IIA and criptothanshinone, that are present in both Salvia species, and on przewaquinone A (Figure 12 ), that is found only in Salvia przewalskii. They found that all three compounds were able to inhibit contraction of the isolated porcine coronary artery in response to the thromboxane A 2 analogue, U46619; however, the most active was przewaquinone A. Authors conclude that przewaquinone A is the most responsible for the vasorelaxant effect of the Salvia przewalskii.
Tanshinone IIA and cryptotanshinone have also shown to have metabolic effect; indeed, they are able to induce CYP3A4 at transcriptional level, by activating human pregnane X receptor (PXR) on HepG2 cells [53] .
Tanshinone IIB (Figure 11 ), a major active constituent from Salvia miltiorrhiza, whose roots are used in the treatment of acute stroke [54, 55] , protects rat brain from damage induced by experimental stroke, in vivo [56] .
Successively, it has been demonstrated that tanshinone IIB inhibits apoptosis of rat primary cortical cells induced by staurosporine in vitro, suggesting a possible neuroprotective activity [57] .
Tanshinone congeners, such as tanshinone I, tanshinone IIA, cryptotanshinone and 15,16-dihydrotanshinone I, significantly reverse scopolamine-induced cognitive impairments and ameliorate diazepam induced memory impairments in mice. The effect of cryptotanshinone and 15, 16-dihydrotanshinone I seems to be related to an increase of cholinergic signalling though acethylcholinesterase (AchE) inhibition; while, the effect of tanshinone I and tanshinone IIA, that do not affect AchE, has been speculated to be dependent on their ability to bind GABAA/benzodiazepine receptor [58] . More recently, it has been shown that tanshinone I enhance learning and memory in mice by activating extracellular signal-regulated kinase (ERK) / cAMP response elementbinding (CREB) signalling [59] .
Cryptotanshinone has been shown to modulate amyloid precursor protein metabolism and to attenuate betaamyloid deposition through an up regulation of alphasecretase activity, suggesting a protective role in Alzheimer disease [60] .
Another compound named tanshinlactone A ( Figure 11 ) was isolated from Salvia miltiorrhiza [61] . By an in vitro study performed on human peripheral blood mononuclear cells (PBMC) stimulated with phytohemagglutinin, it has been reported that tanshinlactone A has an antiproliferative effect; it reduces mitogen-activated protein kinases (MAPK) activation and interleukin-2 (IL-2) and interferon-gamma (IFN-γ) production suggesting a possible immunomodulatory activity [62] . (Figure 13 ). Most of them possess activity against several strains of pathogens. The icetaxan lanigerol, from Salvia lanigera, is active against Bacillus subtilis and Mycobacterium luteus [63] . Brussonol, from Salvia broussonetii, was found to exert moderate citotoxicity against insect Sf9 cells [64, 65] . 5epi-icetexone, from Salvia gilliessi, has been found to exert an antiproliferative against Trypanosoma cruzi with low toxicity, only at very high concentration (more than 4.2 µM) for mammalian cells [66, 67] . Two new icetaxane diterpenes quinones, fruticuline A and demethylfruticuline A (Figure 13 ), have been obtained from Salvia corrugata. In a recent work from Bisio et al. [68] the antibacterial activity of both compounds has been evaluated against 46 pathogens; it has been demonstrated that demethylfruticulin A is highly bactericidal against Staphylococcus aureus and S. epidermidis and bacteriostatic against Enterococcus faecalis and E. faecium. Fruticuline A manifests only bacteriostatic activity but against all strains tested [68] .
Furthermore, demethylfruticulin A has been shown to induce a special form of apoptosis, named "anoikis", of mammalian cell line [69] . Another icetaxane, the compound 19(R)-acetoxy-19deoxoicetexone ( Figure 13 ), has been isolated from Salvia pubescens and displays moderate antibacterial activity against Escherichia coli [65, 70] . (Figure 14) , has been recently isolated from Salvia cinnabarina. 3,4-secoisopimar-4(18),7,15-triene-3-oic acid has intestinal spasmolytic activity in vitro, in rat, with an aspecific mechanism [71] . Successively, studies in vivo, have shown that the same compound inhibits mouse intestinal motility with a mechanism involving L-type Ca 2+ channels [72] and, in vitro, it inhibits rat bladder contractility with the partial involvement of nitric oxide [73] . In addition, 3,4secoisopimar-4(18),7,15-triene-3-oic acid has been shown to possess a weak hypotensive activity in vivo in rats [74] Biological activity of bicyclic and tricyclic diterpenoids Natural Product Communications Vol. 6 (8) 2011 1211 and pronounced CNS depressant properties, manifested as sedation and anxiolytic effects [75] . More recently, the above secoisopimarane diterpenoid has been shown to be antimutagenic in Ames test [76] .
Another compound with a pimarane skeleton, isopimaric acid (Figure 14) , has been isolated from Salvia jamensis and it has been shown to inhibit ADP-induced rat platelet aggregation in vitro and to have phytotoxic activity against Papaver rhoes and Avena sativa [16, 77] .
Concluding Remarks
It is known that plants have played an important part in the development of new drugs and it is estimated that at least 25 % of the molecules currently used as prescribed drugs originate, directly or indirectly, from plant sources [78] . Efforts direct to obtain the active principle(s) from plants of genus Salvia have led to identify a class of compounds of diterpenoid and triterpenoid structures. Here, we have summarized the main diterpenoids from several Salvia species and their main biological activities.
Vegetal drugs might represent a precious source of therapeutically active substances, especially in those countries that reveal a strong vitality of traditional medicine, such as China, India and Japan. However, nowadays a renewed interest for vegetal drugs all around the world has been growing. Several clinical trials have been performed in order to confirm findings obtained from experimental studies and to evaluate the therapeutic potential of Salvia species. However, most of the clinical studies have investigated the effect of several Salvia species extracts. In the last ten years, clinical studies have shown the potential therapeutic effects of Salvia miltiorrhiza, Salvia officinalis and Salvia hispanica for cardiovascular diseases [79] [80] [81] [82] [83] [84] [85] [86] [87] ; for cognitive diseases [88] [89] [90] [91] [92] ; for traumatic and inflammatory diseases [84, [93] [94] [95] [96] [97] [98] ; for liver diseases [99] [100] [101] [102] ; for cancer [103] ; for hypercholesterolemia [104] ; in organ transplantation [105] and for treating vasovagal syncope [106] but there are only few trials evaluating the effect of active principles contained into the vegetal drugs. Among diterpenoids from Salvia species, the lipidic fraction of Salvia officinalis, rich in phenolic diterpenes, carnosic acid and carnosol ( Figure  6 ), has been shown to protect from ultraviolet rayinduced skin erythema in volunteers [107] . More recently, sulphotanshinone, a semi synthetic derivative, have been analyzed in patients affected by angina pectoris [108] . Anyway, in the table (Table 1) we have made a synopsis of the biological activity of the diterpenes from Salvia species; as expected the antimicrobic activity and the cytotoxic activity are the most recurrent following by cardiovascular and antinflammatory activities.
In conclusion, diterpenoids from Salvia species continue to be a plant defence system and some of them are going to be promising candidates for the development of new therapeutic agents.
